Patient Five Cancer-Free Twelve Months After Single Anti-Cancer Treatment
reddit -

The Study's purpose was to evaluate TLD-1433, Theralase's lead PDC, for the primary endpoint of safety and tolerability, secondary endpoint of pharmacokinetics (movement and exit of drug within tissue) and exploratory endpoint of efficacy, primarily at 90 days and secondarily at 180 days post treatment.

Read this story at

Loading...

Related Articles